Table 7.
Cumulative recurrent PAF* at the end of follow-up in the second investigation.
| Groups (case number) | Male | Female | ||
|---|---|---|---|---|
| Total number | Cumulative recurrent PAF | Total number | Cumulative recurrent PAF | |
| WK* treatment (54 cases) | 27 | 0 | 27 | 1 |
| Sotalol treatment (54 cases) | 27 | 2 | 27 | 0 |
| Control (55 cases) | 35 | 4 | 20 | 5 |
|
| ||||
| χ 2 value (P value)(WK) : (control) ∗∗ | 6.886 (0.009) | |||
| χ 2 value (P value)(sotalol) : (control) ∗∗ | 4.813 (0.028) | |||
| χ 2 value (P value)(WK) : (sotalol) ∗∗ | 0.343 (0.558) | |||
∗WK: Wenxin Keli; PAF: paroxysmal atrial fibrillation; **analyzed by χ 2 test.